Company Filing History:
4 out of 10 
1 out of 346 
1 out of 1 Years Active: 2013-2019
Title: The Innovative Journey of Heiko Hawlisch
Introduction
Heiko Hawlisch, an accomplished inventor based in Berlin, Germany, is known for his significant contributions to the field of pharmaceutical sciences. With a total of six patents to his name, his innovative work focuses on novel compounds that hold promise in therapeutic applications.
Latest Patents
Among his latest patents are the NPR-B agonists. These patents disclose novel compounds exhibiting NPR-B agonistic activity, which are primarily linear peptides consisting of 8 to 13 conventional or non-conventional L- or D-amino acid residues. These residues are uniquely connected through peptide bonds, showcasing Hawlisch's expertise in peptide chemistry.
Career Highlights
Throughout his career, Heiko has made notable advancements while working in esteemed organizations such as Shire Orphan Therapies GmbH and Alcon Research, Ltd. His innovative mindset and dedication to research have made a significant impact in the pharmaceutical industry.
Collaborations
Heiko has collaborated with remarkable professionals, including Frank Osterkamp and Gerd Hummel. These collaborations highlight not only his ability to work within teams but also the collective drive towards breakthroughs in the field of pharmacology.
Conclusion
Heiko Hawlisch's work exemplifies the spirit of innovation and dedication within the scientific community. By continuously advancing the understanding and applications of NPR-B agonists, he paves the way for future therapeutic possibilities that may benefit patients worldwide.